First Phosphate’s high-purity phosphate ore can be fully and sustainably refined into battery-grade material without ...

The Trump administration appears to be fast-tracking an Australian company’s lithium project in southeastern Oregon. The U.S. Bureau of Land Management on Wednesday published its environmental ...

April 3 (Reuters) - Australia's Galan Lithium (GLN.AX), opens new tab said on Thursday that it rejected an offer from Zhejiang Huayou Cobalt Co (603799.SS), opens new tab and Renault Group (RENA ...

April 1 (Reuters) - Lithium Americas (LAC.TO), opens new tab said on Tuesday it has reached a final investment decision (FID) for constructing the first phase of the Thacker Pass lithium mine in ...

Merck & Co.’s subcutaneous (SC) formulation of Keytruda has matched up to the original intravenous (IV) version on two blood concentration measurements, paving way for a potential FDA approval ...

Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong ...

40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...

Freshwater availability for lithium mining in the Lithium Triangle is significantly overestimated, with actual inflow ranging from 2 to 33 mm per year, contrary to previous estimates of 90 to 230 mm.

The EU list – which can be explored in an interactive map – includes industrial projects to mine or process lithium in Portugal, Spain, France, Germany, Czechia and Finland.

Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, the US drugmaker’s second recent foray into China for a novel medicine.